Results 161 to 170 of about 1,717,717 (307)

Bioinformatics driven in gene targeting platform for gold anticancer strategy delivery. [PDF]

Mater Today Bio
Jiang C, Wen H, Chen J, Han N, Sun X, Zhang Y, Hu Y, Shu G, Yin G, Wang M.   +9 more
europepmc   +1 more source

Combinatorial gene targeting in primary human hematopoietic stem and progenitor cells. [PDF]

Sci Rep, 2022
Bäckström A, Yudovich D, Žemaitis K, Nilsén Falck L, Subramaniam A, Larsson J.   +5 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Development of Modular Geminivirus-Based Vectors for High Cargo Expression and Gene Targeting in Plants. [PDF]

Plant Biotechnol J
Neubauer M, Vollen K, Zhao C, Ascencio-Ibáñez JT, Hanley-Bowdoin L, Stepanova AN, Alonso JM.   +6 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

SSA-mediated selection marker gene activation enhances relative gene targeting efficiency in plants. [PDF]

Hortic Res
Kong D, Cheng Y, Ke Y, Dang X, Liu X, Wang C, Huang C, Ye R, Miki D.   +8 more
europepmc   +1 more source

Gene targeting techniques for Huntington's disease. [PDF]

Ageing Res Rev, 2021
Fields E, Vaughan E, Tripu D, Lim I, Shrout K, Conway J, Salib N, Lee Y, Dhamsania A, Jacobsen M, Woo A, Xue H, Cao K.   +12 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Novel Therapies in Advanced Pancreatic Cancer: A Peak Beyond the Realms of Gene Targeting. [PDF]

Cureus
Dave P, Beriwala V, Parikh C, Uddin A, Dayala H, Patel RH, Chirumamilla PC, Winer A.   +7 more
europepmc   +1 more source

Immortalization of primary marmoset skin fibroblasts by CRISPR-Cas9-mediated gene targeting. [PDF]

Anim Cells Syst (Seoul), 2022
Jeong YJ, Cho J, Kwak J, Sung YH, Kang BC.   +4 more
europepmc   +1 more source